Okuda Y - Search Results

1

Relationship between gene mutations and clinicopathological features in nonampullary duodenal epithelial tumors.

Fukusada S, Shimura T, Iwasaki H, Okuda Y, Katano T, Ozeki T, Kitagawa M, Nishie H, Tanaka M, Ozeki K, Kubota E, Tanida S, Kataoka H. Fukusada S, et al. Among authors: okuda y. Dig Liver Dis. 2022 Jul;54(7):905-910. doi: 10.1016/j.dld.2021.12.004. Epub 2021 Dec 24. Dig Liver Dis. 2022. PMID: 34961702

2

Long-term Outcomes of One Stage Surgery Using Transanal Colorectal Tube for Acute Colorectal Obstruction of Stage II/III Distal Colon Cancer.

Okuda Y, Yamada T, Hirata Y, Shimura T, Yamaguchi R, Sakamoto E, Sobue S, Nakazawa T, Kataoka H, Joh T. Okuda Y, et al. Cancer Res Treat. 2019 Apr;51(2):474-482. doi: 10.4143/crt.2018.059. Epub 2018 Jun 6. Cancer Res Treat. 2019. PMID: 29879759 Free PMC article.

3

Colorectal obstruction is a potential prognostic factor for stage II colorectal cancer.

Okuda Y, Shimura T, Yamada T, Hirata Y, Yamaguchi R, Sakamoto E, Kataoka H. Okuda Y, et al. Int J Clin Oncol. 2018 Dec;23(6):1101-1111. doi: 10.1007/s10147-018-1307-2. Epub 2018 Jun 15. Int J Clin Oncol. 2018. PMID: 29948240

4

Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer.

Natsume M, Shimura T, Iwasaki H, Okuda Y, Kitagawa M, Okamoto Y, Hayashi K, Kataoka H. Natsume M, et al. Among authors: okuda y. Cancer Chemother Pharmacol. 2019 Jun;83(6):1037-1046. doi: 10.1007/s00280-019-03817-2. Epub 2019 Mar 21. Cancer Chemother Pharmacol. 2019. PMID: 30899983

5

A novel urinary microRNA biomarker panel for detecting gastric cancer.

Iwasaki H, Shimura T, Yamada T, Okuda Y, Natsume M, Kitagawa M, Horike SI, Kataoka H. Iwasaki H, et al. Among authors: okuda y. J Gastroenterol. 2019 Dec;54(12):1061-1069. doi: 10.1007/s00535-019-01601-w. Epub 2019 Jun 25. J Gastroenterol. 2019. PMID: 31240436

6

Pathological impact of transanal colorectal tube for obstructive colorectal cancer.

Okuda Y, Shimura T, Kato H, Yamada T, Hirata Y, Natsume M, Iwasaki H, Yamaguchi R, Sakamoto E, Takahashi S, Kataoka H. Okuda Y, et al. Surg Endosc. 2020 Sep;34(9):4011-4018. doi: 10.1007/s00464-019-07188-w. Epub 2019 Oct 17. Surg Endosc. 2020. PMID: 31624940

7

Correction to: Pathological impact of transanal colorectal tube for obstructive colorectal cancer.

Okuda Y, Shimura T, Kato H, Yamada T, Hirata Y, Natsume M, Iwasaki H, Yamaguchi R, Sakamoto E, Takahashi S, Kataoka H. Okuda Y, et al. Surg Endosc. 2020 Sep;34(9):4019. doi: 10.1007/s00464-019-07230-x. Surg Endosc. 2020. PMID: 31659504

8

Omental adipocytes promote peritoneal metastasis of gastric cancer through the CXCL2-VEGFA axis.

Natsume M, Shimura T, Iwasaki H, Okuda Y, Hayashi K, Takahashi S, Kataoka H. Natsume M, et al. Among authors: okuda y. Br J Cancer. 2020 Aug;123(3):459-470. doi: 10.1038/s41416-020-0898-3. Epub 2020 May 22. Br J Cancer. 2020. PMID: 32439934 Free PMC article.

9

Novel urinary protein biomarker panel for early diagnosis of gastric cancer.

Shimura T, Dayde D, Wang H, Okuda Y, Iwasaki H, Ebi M, Kitagawa M, Yamada T, Yamada T, Hanash SM, Taguchi A, Kataoka H. Shimura T, et al. Among authors: okuda y. Br J Cancer. 2020 Nov;123(11):1656-1664. doi: 10.1038/s41416-020-01063-5. Epub 2020 Sep 16. Br J Cancer. 2020. PMID: 32934343 Free PMC article.

10

Serum Exosomal Dicer Is a Useful Biomarker for Early Detection of Differentiated Gastric Adenocarcinoma.

Okuda Y, Shimura T, Iwasaki H, Katano T, Kitagawa M, Nishigaki R, Fukusada S, Natsume M, Tanaka M, Nishie H, Ozeki K, Yamada T, Kataoka H. Okuda Y, et al. Digestion. 2021;102(4):640-649. doi: 10.1159/000510993. Epub 2020 Oct 13. Digestion. 2021. PMID: 33049740

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,157 results

Search Page